New York, NY · Founded 2023 · Privately Held (backing)
Developer of an artificial intelligence clinical trial development platform designed to uncover new biology and biomarkers that predict patient response. Numenos is based in New York, NY and was founded in 2023. Its last reported valuation was $21.8 million in Jan 2025. It has raised $7.7 million.
Last reported valuation
$21.8M
Oct 2026
Priced at
—
Total raised
$7.7M
Last round
—
Cap table — not yet on record
Numenos's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Numenos with a free account
·Watch Numenos: the Monday email on marks, rounds and moves
